SC
EGRX

Sculptor Capital’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Sculptor Capital’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-5,800
Closed -$406K – 265
2016
Q3 		$406K Buy
+5,800
New +$406K ﹤0.01% 163